Evan Seigerman Score: 37
Analyst at
BMO Capital
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+13.2%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
63%
27 W / 16 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
77%
24 W / 7 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
10%
3 W / 28 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 31 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
50%
9 W / 9 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
66%
25 W / 13 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
40%
2 W / 3 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,650.00
Est. +20%
|
$1,373.00 | $1,449.68 |
Pending
|
$1,417.83
+3.3%
|
| Sep 01, 2026 |
Protagonist Therapeutics Inc
PTGX
|
BUY |
$190.00
Est. +29%
|
$147.75 | $151.83 |
Pending
|
$143.37
-3.0%
|
| Aug 06, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,400.00
Est. +20%
|
$1,169.86 | $1,449.68 |
Target Met
|
$1,417.83
+21.2%
|
| Aug 06, 2026 |
Novo Nordisk - ADR
NVO
|
BUY |
$47.00
Est. +6%
|
$44.51 | $48.66 |
Target Met
|
$42.17
-5.3%
|
| Aug 05, 2026 |
AMGEN Inc.
AMGN
|
BUY |
$450.00
Est. +15%
|
$390.02 | $482.48 |
Target Met
|
$478.48
+22.7%
|
| Jun 30, 2026 |
Replimune Group Inc
REPL
|
BUY |
$16.00
Est. +43%
|
$11.20 | $21.26 |
Target Met
|
$20.69
+84.7%
|
| Mar 17, 2026 |
Structure Therapeutics Inc - ADR
GPCR
|
BUY |
$145.00
Est. +155%
|
$56.88 | $57.47 |
Pending
|
$20.36
-64.2%
|
| Feb 17, 2026 |
Disc Medicine Inc
IRON
|
BUY |
$100.00
Est. +63%
|
$61.48 | $85.00 |
Pending
|
$83.28
+35.5%
|
| Feb 11, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$160.00
Est. +9%
|
$147.23 | $175.65 |
Target Met
|
$174.48
+18.5%
|
| Feb 06, 2026 |
Biogen Inc
BIIB
|
SELL |
$196.00
Est. +3%
|
$201.18 | $168.64 (Low) |
Target Met
|
$254.46
-26.5%
|
| Feb 05, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,300.00
Est. +17%
|
$1,107.12 | $1,449.68 |
Target Met
|
$1,417.83
+28.1%
|
| Jan 26, 2026 |
Novo Nordisk - ADR
NVO
|
SELL |
$57.00
Est. +11%
|
$63.80 | $35.12 (Low) |
Target Met
|
$42.17
+33.9%
|
| Dec 04, 2025 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$850.00
Est. +17%
|
$723.67 | $991.73 |
Target Met
|
$930.67
+28.6%
|
| Dec 03, 2025 |
AMGEN Inc.
AMGN
|
BUY |
$372.00
Est. +10%
|
$338.36 | $482.48 |
Target Met
|
$478.48
+41.4%
|
| Dec 02, 2025 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,100.00
Est. +4%
|
$1,058.48 | $1,449.68 |
Target Met
|
$1,417.83
+33.9%
|
| Nov 25, 2025 |
Novo Nordisk - ADR
NVO
|
BUY |
$46.00
Est. +2%
|
$44.97 | $64.16 |
Target Met
|
$42.17
-6.2%
|
| Nov 03, 2025 |
Replimune Group Inc
REPL
|
BUY |
$11.00
Est. +13%
|
$9.73 | $21.26 |
Target Met
|
$20.69
+112.6%
|
| Nov 03, 2025 |
Terns Pharmaceuticals Inc
TERN
|
BUY |
$22.00
Est. +57%
|
$14.03 | $53.18 |
Target Met
|
$52.95
+277.4%
|
| Oct 29, 2025 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$725.00
Est. +11%
|
$654.48 | $859.34 |
Target Met
|
$930.67
+42.2%
|
| Oct 14, 2025 |
Novo Nordisk - ADR
NVO
|
SELL |
$55.00
Est. +4%
|
$57.50 | $35.12 (Low) |
Target Met
|
$42.17
+26.7%
|
| Apr 25, 2025 |
Merck & Co Inc
MRK
|
SELL |
$82.00
Est. +1%
|
$82.74 | $73.31 (Low) |
Target Met
|
$150.39
-81.8%
|
| Feb 03, 2025 |
Abbvie Inc
ABBV
|
BUY |
$215.00
Est. +13%
|
$190.14 | $244.81 |
Target Met
|
$294.90
+55.1%
|
| Jan 31, 2025 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$545.00
Est. +18%
|
$461.68 | $519.68 |
Miss
|
$549.04
+18.9%
|
| Jan 22, 2025 |
Replimune Group Inc
REPL
|
BUY |
$27.00
Est. +106%
|
$13.09 | $14.80 |
Miss
|
$20.69
+58.1%
|
| Nov 12, 2024 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$61.00
Est. +8%
|
$56.23 | $63.33 |
Target Met
|
$64.20
+14.2%
|
| Oct 17, 2024 |
Biogen Inc
BIIB
|
BUY |
$230.00
Est. +22%
|
$188.17 | $191.19 |
Miss
|
$254.46
+35.2%
|
| Oct 17, 2024 |
Novo Nordisk - ADR
NVO
|
BUY |
$156.00
Est. +32%
|
$118.58 | $119.07 |
Miss
|
$42.17
-64.4%
|
| Jul 19, 2024 |
Abbvie Inc
ABBV
|
BUY |
$214.00
Est. +24%
|
$172.01 | $218.66 |
Precision Hit (±3%)
|
$294.90
+71.4%
|
| Jul 02, 2024 |
Incyte Corp.
INCY
|
SELL |
$48.00
Est. +21%
|
$60.87 | $53.56 (Low) |
Miss
|
$122.89
-101.9%
|
| Jun 07, 2024 |
Structure Therapeutics Inc - ADR
GPCR
|
BUY |
$100.00
Est. +88%
|
$53.07 | $47.43 |
Miss
|
$20.36
-61.6%
|
| May 22, 2024 |
Pfizer Inc.
PFE
|
BUY |
$36.00
Est. +22%
|
$29.60 | $31.54 |
Miss
|
$30.79
+4.0%
|
| May 17, 2024 |
Replimune Group Inc
REPL
|
BUY |
$14.00
Est. +104%
|
$6.85 | $16.55 |
Target Met
|
$20.69
+202.0%
|
| May 01, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,001.00
Est. +28%
|
$781.10 | $972.53 |
Precision Hit (±3%)
|
$1,417.83
+81.5%
|
| Apr 29, 2024 |
Abbvie Inc
ABBV
|
BUY |
$180.00
Est. +14%
|
$158.58 | $218.66 |
Target Met
|
$294.90
+86.0%
|
| Nov 27, 2023 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$60.00
Est. +21%
|
$49.76 | $61.08 |
Precision Hit (±3%)
|
$64.20
+29.0%
|
| Dec 07, 2022 |
Mirati Therapeutics Inc
MRTX
|
BUY |
$59.00
Est. +19%
|
$49.59 | - | - |
$58.70
+18.4%
|
| May 02, 2022 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$87.00
Est. +16%
|
$75.08 | - | - |
$64.20
-14.5%
|
| Apr 29, 2022 |
AMGEN Inc.
AMGN
|
BUY |
$243.00
Est. +2%
|
$238.13 | - | - |
$478.48
+100.9%
|
| Apr 04, 2022 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$81.00
Est. +10%
|
$73.79 | - | - |
$64.20
-13.0%
|
| Mar 22, 2022 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$274.00
Est. +9%
|
$251.88 | - | - |
$549.04
+118.0%
|
| Mar 15, 2022 |
Biogen Inc
BIIB
|
BUY |
$238.00
Est. +21%
|
$197.36 | - | - |
$254.46
+28.9%
|
| Feb 08, 2022 |
Incyte Corp.
INCY
|
BUY |
$75.00
Est. +7%
|
$70.07 | - | - |
$122.89
+75.4%
|
| Jan 15, 2022 |
Pfizer Inc.
PFE
|
BUY |
$76.00
Est. +38%
|
$54.95 | - | - |
$30.79
-44.0%
|
Lilly(Eli) & Co
LLY
Oct 30, 2026
Signal & Target
BUY
$1,650.00
Start Price
$1,373.00
Best Price (1Y)
$1,449.68
Current Price
$1,417.83
Return
+3.3%
Protagonist Therapeutics Inc
PTGX
Sep 01, 2026
Signal & Target
BUY
$190.00
Start Price
$147.75
Best Price (1Y)
$151.83
Current Price
$143.37
Return
-3.0%
Lilly(Eli) & Co
LLY
Aug 06, 2026
Signal & Target
BUY
$1,400.00
Start Price
$1,169.86
Best Price (1Y)
$1,449.68
Current Price
$1,417.83
Return
+21.2%
Novo Nordisk - ADR
NVO
Aug 06, 2026
Signal & Target
BUY
$47.00
Start Price
$44.51
Best Price (1Y)
$48.66
Current Price
$42.17
Return
-5.3%
AMGEN Inc.
AMGN
Aug 05, 2026
Signal & Target
BUY
$450.00
Start Price
$390.02
Best Price (1Y)
$482.48
Current Price
$478.48
Return
+22.7%
Replimune Group Inc
REPL
Jun 30, 2026
Signal & Target
BUY
$16.00
Start Price
$11.20
Best Price (1Y)
$21.26
Current Price
$20.69
Return
+84.7%
Structure Therapeutics Inc - ADR
GPCR
Mar 17, 2026
Signal & Target
BUY
$145.00
Start Price
$56.88
Best Price (1Y)
$57.47
Current Price
$20.36
Return
-64.2%
Disc Medicine Inc
IRON
Feb 17, 2026
Signal & Target
BUY
$100.00
Start Price
$61.48
Best Price (1Y)
$85.00
Current Price
$83.28
Return
+35.5%
Gilead Sciences, Inc.
GILD
Feb 11, 2026
Signal & Target
BUY
$160.00
Start Price
$147.23
Best Price (1Y)
$175.65
Current Price
$174.48
Return
+18.5%
Biogen Inc
BIIB
Feb 06, 2026
Signal & Target
SELL
$196.00
Start Price
$201.18
Best Price (1Y)
$168.64
Current Price
$254.46
Return
-26.5%
Lilly(Eli) & Co
LLY
Feb 05, 2026
Signal & Target
BUY
$1,300.00
Start Price
$1,107.12
Best Price (1Y)
$1,449.68
Current Price
$1,417.83
Return
+28.1%
Novo Nordisk - ADR
NVO
Jan 26, 2026
Signal & Target
SELL
$57.00
Start Price
$63.80
Best Price (1Y)
$35.12
Current Price
$42.17
Return
+33.9%
Regeneron Pharmaceuticals, Inc.
REGN
Dec 04, 2025
Signal & Target
BUY
$850.00
Start Price
$723.67
Best Price (1Y)
$991.73
Current Price
$930.67
Return
+28.6%
AMGEN Inc.
AMGN
Dec 03, 2025
Signal & Target
BUY
$372.00
Start Price
$338.36
Best Price (1Y)
$482.48
Current Price
$478.48
Return
+41.4%
Lilly(Eli) & Co
LLY
Dec 02, 2025
Signal & Target
BUY
$1,100.00
Start Price
$1,058.48
Best Price (1Y)
$1,449.68
Current Price
$1,417.83
Return
+33.9%
Novo Nordisk - ADR
NVO
Nov 25, 2025
Signal & Target
BUY
$46.00
Start Price
$44.97
Best Price (1Y)
$64.16
Current Price
$42.17
Return
-6.2%
Replimune Group Inc
REPL
Nov 03, 2025
Signal & Target
BUY
$11.00
Start Price
$9.73
Best Price (1Y)
$21.26
Current Price
$20.69
Return
+112.6%
Terns Pharmaceuticals Inc
TERN
Nov 03, 2025
Signal & Target
BUY
$22.00
Start Price
$14.03
Best Price (1Y)
$53.18
Current Price
$52.95
Return
+277.4%
Regeneron Pharmaceuticals, Inc.
REGN
Oct 29, 2025
Signal & Target
BUY
$725.00
Start Price
$654.48
Best Price (1Y)
$859.34
Current Price
$930.67
Return
+42.2%
Novo Nordisk - ADR
NVO
Oct 14, 2025
Signal & Target
SELL
$55.00
Start Price
$57.50
Best Price (1Y)
$35.12
Current Price
$42.17
Return
+26.7%
Merck & Co Inc
MRK
Apr 25, 2025
Signal & Target
SELL
$82.00
Start Price
$82.74
Best Price (1Y)
$73.31
Current Price
$150.39
Return
-81.8%
Abbvie Inc
ABBV
Feb 03, 2025
Signal & Target
BUY
$215.00
Start Price
$190.14
Best Price (1Y)
$244.81
Current Price
$294.90
Return
+55.1%
Vertex Pharmaceuticals, Inc.
VRTX
Jan 31, 2025
Signal & Target
BUY
$545.00
Start Price
$461.68
Best Price (1Y)
$519.68
Current Price
$549.04
Return
+18.9%
Replimune Group Inc
REPL
Jan 22, 2025
Signal & Target
BUY
$27.00
Start Price
$13.09
Best Price (1Y)
$14.80
Current Price
$20.69
Return
+58.1%
Bristol-Myers Squibb Co.
BMY
Nov 12, 2024
Signal & Target
BUY
$61.00
Start Price
$56.23
Best Price (1Y)
$63.33
Current Price
$64.20
Return
+14.2%
Biogen Inc
BIIB
Oct 17, 2024
Signal & Target
BUY
$230.00
Start Price
$188.17
Best Price (1Y)
$191.19
Current Price
$254.46
Return
+35.2%
Novo Nordisk - ADR
NVO
Oct 17, 2024
Signal & Target
BUY
$156.00
Start Price
$118.58
Best Price (1Y)
$119.07
Current Price
$42.17
Return
-64.4%
Abbvie Inc
ABBV
Jul 19, 2024
Signal & Target
BUY
$214.00
Start Price
$172.01
Best Price (1Y)
$218.66
Current Price
$294.90
Return
+71.4%
Incyte Corp.
INCY
Jul 02, 2024
Signal & Target
SELL
$48.00
Start Price
$60.87
Best Price (1Y)
$53.56
Current Price
$122.89
Return
-101.9%
Structure Therapeutics Inc - ADR
GPCR
Jun 07, 2024
Signal & Target
BUY
$100.00
Start Price
$53.07
Best Price (1Y)
$47.43
Current Price
$20.36
Return
-61.6%
Pfizer Inc.
PFE
May 22, 2024
Signal & Target
BUY
$36.00
Start Price
$29.60
Best Price (1Y)
$31.54
Current Price
$30.79
Return
+4.0%
Replimune Group Inc
REPL
May 17, 2024
Signal & Target
BUY
$14.00
Start Price
$6.85
Best Price (1Y)
$16.55
Current Price
$20.69
Return
+202.0%
Lilly(Eli) & Co
LLY
May 01, 2024
Signal & Target
BUY
$1,001.00
Start Price
$781.10
Best Price (1Y)
$972.53
Current Price
$1,417.83
Return
+81.5%
Abbvie Inc
ABBV
Apr 29, 2024
Signal & Target
BUY
$180.00
Start Price
$158.58
Best Price (1Y)
$218.66
Current Price
$294.90
Return
+86.0%
Bristol-Myers Squibb Co.
BMY
Nov 27, 2023
Signal & Target
BUY
$60.00
Start Price
$49.76
Best Price (1Y)
$61.08
Current Price
$64.20
Return
+29.0%
Mirati Therapeutics Inc
MRTX
Dec 07, 2022
Signal & Target
BUY
$59.00
Start Price
$49.59
Best Price (1Y)
-
Current Price
$58.70
Return
+18.4%
Bristol-Myers Squibb Co.
BMY
May 02, 2022
Signal & Target
BUY
$87.00
Start Price
$75.08
Best Price (1Y)
-
Current Price
$64.20
Return
-14.5%
AMGEN Inc.
AMGN
Apr 29, 2022
Signal & Target
BUY
$243.00
Start Price
$238.13
Best Price (1Y)
-
Current Price
$478.48
Return
+100.9%
Bristol-Myers Squibb Co.
BMY
Apr 04, 2022
Signal & Target
BUY
$81.00
Start Price
$73.79
Best Price (1Y)
-
Current Price
$64.20
Return
-13.0%
Vertex Pharmaceuticals, Inc.
VRTX
Mar 22, 2022
Signal & Target
BUY
$274.00
Start Price
$251.88
Best Price (1Y)
-
Current Price
$549.04
Return
+118.0%
Biogen Inc
BIIB
Mar 15, 2022
Signal & Target
BUY
$238.00
Start Price
$197.36
Best Price (1Y)
-
Current Price
$254.46
Return
+28.9%
Incyte Corp.
INCY
Feb 08, 2022
Signal & Target
BUY
$75.00
Start Price
$70.07
Best Price (1Y)
-
Current Price
$122.89
Return
+75.4%
Pfizer Inc.
PFE
Jan 15, 2022
Signal & Target
BUY
$76.00
Start Price
$54.95
Best Price (1Y)
-
Current Price
$30.79
Return
-44.0%